ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04360	Axon guidance	19/116	233/7206	4.13844396765e-09
ko05200	Pathways in cancer	24/116	492/7206	7.12555632004e-07
ko04390	Hippo signaling pathway	13/116	188/7206	8.97351101825e-06
ko04151	PI3K-Akt signaling pathway	17/116	390/7206	0.000150605545578
ko05212	Pancreatic cancer	7/116	83/7206	0.000353410224794
ko05220	Chronic myeloid leukemia	7/116	85/7206	0.000409175630019
ko04391	Hippo signaling pathway - fly	7/116	90/7206	0.000579772466605
ko04350	TGF-beta signaling pathway	7/116	103/7206	0.00129515710499
ko05224	Breast cancer	9/116	174/7206	0.00188754855704
ko04340	Hedgehog signaling pathway	5/116	58/7206	0.00230196551752
ko04310	Wnt signaling pathway	9/116	181/7206	0.00247177294378
ko05222	Small cell lung cancer	6/116	89/7206	0.00299935829942
ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	3/116	19/7206	0.00326340343021
ko05217	Basal cell carcinoma	5/116	68/7206	0.0046116833124
ko04550	Signaling pathways regulating pluripotency of stem cells	8/116	165/7206	0.00498537698154
ko04510	Focal adhesion	10/116	240/7206	0.00514906618711
ko04520	Adherens junction	6/116	103/7206	0.00615634228242
ko05166	HTLV-I infection	11/116	292/7206	0.00715693694909
ko05206	MicroRNAs in cancer	8/116	177/7206	0.00754712096497
ko04218	Cellular senescence	8/116	177/7206	0.00754712096497
ko00534	Glycosaminoglycan biosynthesis - heparan sulfate / heparin	3/116	26/7206	0.00806909030915
ko04919	Thyroid hormone signaling pathway	7/116	143/7206	0.00807808091596
ko04512	ECM-receptor interaction	5/116	79/7206	0.00867377773306
ko05205	Proteoglycans in cancer	10/116	271/7206	0.0117103732945
ko05210	Colorectal cancer	5/116	86/7206	0.0122693443036
ko04392	Hippo signaling pathway -multiple species	3/116	31/7206	0.0131625825291
ko05161	Hepatitis B	7/116	173/7206	0.0212638433985
ko05100	Bacterial invasion of epithelial cells	5/116	99/7206	0.0213959875119
ko04144	Endocytosis	11/116	342/7206	0.024791498552
ko04659	Th17 cell differentiation	5/116	106/7206	0.0277697410093
ko01521	EGFR tyrosine kinase inhibitor resistance	5/116	106/7206	0.0277697410093
ko04110	Cell cycle	6/116	145/7206	0.0291698646312
ko05202	Transcriptional misregulation in cancer	7/116	188/7206	0.031633414697
ko05215	Prostate cancer	5/116	111/7206	0.0329919217368
ko04015	Rap1 signaling pathway	9/116	278/7206	0.0448042218802